Filing Summary
Business Context and Reporting Period
This Form 8-K was filed by Social Capital Hedosophia Holdings Corp. III, a Cayman Islands special purpose acquisition company (SPAC), on April 30, 2020, reporting events occurring on April 24, 2020. The filing predates the company’s later association with Clover Health Investments, Corp.; the source filing identifies the registrant as Social Capital Hedosophia Holdings Corp. III.
Key Financial Metrics and Capitalization
- The company completed its initial public offering of 82.8 million units at $10.00 per unit.
- IPO gross proceeds were $828.0 million, including 10.8 million units issued upon the underwriters’ exercise of their over-allotment option.
- Each unit consisted of one Class A ordinary share and one-third of a redeemable warrant.
- The company separately sold 10,933,333 private placement warrants to its sponsor at $1.50 per warrant, generating gross proceeds of $16.4 million.
- The filing states that $828.0 million was placed in a U.S.-based trust account at JPMorgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee.
- No revenue, net income, operating cash flow, margins, debt, or liquidity metrics beyond the IPO and trust-account balances are reported in the filing.
- An audited balance sheet as of April 24, 2020 was filed as Exhibit 99.1.
Material Changes, Outlook, Risks, and Unusual Items
The material event was the consummation of the IPO and related private warrant placement. The filing does not provide operating guidance, an acquisition target, management outlook, or detailed risk commentary. As a SPAC, the company’s principal reported assets consisted of IPO-related cash held in trust pending a future business combination.
The filing’s wording states that $828.0 million, comprising proceeds from the IPO and private placement warrants, was deposited into the trust account. This amount does not reconcile to the separately disclosed aggregate gross proceeds of $844.4 million, so the audited balance sheet and related trust-account disclosures should be reviewed for the precise allocation of funds and offering expenses.
Facts Investors Should Verify
- Confirm the audited April 24, 2020 balance sheet and the exact amount held in the trust account.
- Reconcile the $828.0 million trust-account amount with total disclosed gross proceeds of $844.4 million.
- Review the terms, redemption provisions, and adjustment features of the public and private placement warrants.
- Verify the company’s subsequent business combination, name change, and transition to Clover Health Investments, Corp., if relevant to the requested issuer.
- Assess the eventual target-company risks and financing terms, which are not provided in this IPO-closing Form 8-K.